On this page
GI-MAP® and GutID® approach the same stool sample from opposite directions. GI-MAP uses quantitative PCR (qPCR) to check the sample for a predefined list of organisms, including parasites, H. pylori and fungi, and a practitioner must order it. GutID uses Titan-1™ long-read sequencing to identify and measure the bacteria in the sample to species, so you see the gut's whole bacterial ecosystem: which species are there, in what proportions, and how the community shifts over time.
If you want the whole picture, that difference matters. Titan-1 reads one continuous stretch of about 2,500 bases of each bacterium's ribosomal DNA, roughly 5–10 times more than a short-read 16S test, and identifies organisms a fixed panel can't, including bacteria that don't yet have a species name; the long-read approach behind it is backed by 30+ peer-reviewed publications. For clinicians who also want targeted markers, GutID Pro puts the full Complete Microbiome Assessment and 65 targeted markers in one kit.
This comparison is for clinicians deciding which test fits a patient's question, and for anyone looking for a GI-MAP alternative they can order themselves.
GI-MAP vs. GutID at a glance
| Attribute | GI-MAP® | GutID (Core and Complete) | GutID Pro |
|---|---|---|---|
| Who orders it | A healthcare practitioner (not available for ordering in New York State) | You order it directly; clinicians can also order through a clinician account | Approved clinicians in the US, for patients 18 and over (not available in New York State) |
| Method | Quantitative PCR (qPCR) that targets the DNA of specific organisms | Titan-1™ long-read sequencing of one continuous region of about 2,500 bases spanning the full 16S rRNA gene, the ITS and the start of the 23S rRNA gene | Titan-1™ sequencing, plus lab panels run by a CLIA laboratory on a second tube from the same collection |
| What it looks for | A predefined panel that includes parasites, bacteria, H. pylori and its virulence factors, fungi and more | Every bacterium in the sample, identified to species, including novel and uncharacterized organisms; no predefined target list | The full Complete Microbiome Assessment, plus 65 markers: a 30-marker GI panel (enteric bacteria, enteric viruses, parasites and Candida species), calprotectin, pancreatic elastase-1, fecal occult blood, H. pylori stool antigen and 31 commensal and dysbiotic bacterial markers |
| What it reports | Quantities of each organism and marker on the panel | The bacterial ecosystem: diversity, balance and each species' relative abundance; Complete adds the gut-brain, gut-immune, gut-metabolism and gut-heart axes | One report: the Complete Microbiome Assessment plus every panel result, with a reference range for each of the 31 bacterial markers |
| Sample | A single stool sample, shipped at room temperature in the vial provided | A stool sample collected at home and processed by a CLIA laboratory in the United States | One collection, two tubes |
| Results time | 7–10 business days, per DSL's site at time of writing | About 3–4 weeks after the lab receives the sample | 3–4 weeks |
| Payment | Diagnostic Solutions Laboratory files claims to insurance and Medicare | Paid directly (US $399 or $599 at time of writing); HSA/FSA eligible in the US | Ordered through a clinician account; clinicians sign in for pricing |
| Suited to | Targeted questions such as suspected infection, parasites, H. pylori or yeast | Seeing the entire bacterial ecosystem and tracking how it changes, without a practitioner's order | Clinicians who want the whole ecosystem and targeted markers from one collection |
How GI-MAP works
GI-MAP (GI Microbial Assay Plus) is run by Diagnostic Solutions Laboratory (DSL). DSL describes it as a comprehensive stool test that uses quantitative polymerase chain reaction (qPCR) to detect parasites, bacteria, H. pylori, fungi and more by targeting the specific DNA of the organisms tested. It also reports H. pylori virulence factors. For the full marker list, see what a GI-MAP tests for.
qPCR is a targeted method. Each assay is designed to find one organism or gene and measure how much of its DNA is in the sample. DSL says this quantification helps practitioners tell trace levels of an organism apart from elevations that suggest active infection, and that a retest after treatment can show whether a parasite has resolved or dysbiosis has improved.
The test uses a single stool sample. A healthcare practitioner has to order it, DSL files claims to insurance and Medicare, and the test can't be ordered in New York State. DSL describes GI-MAP as a diagnostic tool and quotes a current turnaround of 7–10 business days.
Because qPCR finds what it was designed to look for, an organism that isn't on the panel won't appear in the results. That's true of targeted testing in general, and it's the main reason a panel and a sequencing test give such different pictures of the same gut.
How GutID works
Instead of checking a sample against a list, GutID reads the bacteria that are there. Titan-1™ long-read ribosomal sequencing reads one continuous fragment of about 2,500 bases from each bacterium's ribosomal DNA, spanning the full 16S rRNA gene, the internal transcribed spacer (ITS) and the start of the 23S rRNA gene. The fragment comes from a patented amplicon and is read repeatedly, with the passes combined into one consensus sequence. GutID's own classifier then identifies organisms from the whole long read instead of matching short markers to a fixed database, so bacteria are separated and quantified even when no species name exists for them.
The output is species-level identification with relative abundance, built from strain-level data. The report turns it into a picture of the ecosystem: how diverse the community is, which species dominate, which are rare, and how balanced it is. That's the GutID Ecosystem Approach™. The Complete Microbiome Assessment adds the systemic axes: gut-brain, gut-immune, gut-metabolism and gut-heart.
Samples are collected at home and processed by a CLIA laboratory in the United States, with results about 3–4 weeks after the lab receives the sample. Shipping is free both ways, and if a kit arrives damaged or a sample fails because of an error on GutID's side, the replacement is free. You can see a real sample report before you order.
What GutID Pro adds
GutID Pro is the full Complete Microbiome Assessment, plus 65 more markers. The lab panels are included in every kit, run by a CLIA laboratory on a second tube from the same collection:
- A 30-marker GI panel: twelve enteric bacteria, including Salmonella, Campylobacter and the diarrheagenic E. coli groups; six enteric viruses; six parasites; and six Candida species. The panel also reports C. difficile toxin NAAT.
- Stool markers: quantitative calprotectin, pancreatic elastase-1 and fecal occult blood.
- H. pylori stool antigen, reported as detected or not detected.
- 31 commensal and dysbiotic bacterial markers, each with its own reference range.
- Options: fecal leukocytes, and one C. difficile test (NAAT, or GDH and toxin A/B antigen with reflex NAAT).
One collection, two tubes, one report with the full Complete Microbiome Assessment, in 3–4 weeks. GutID Pro is ordered and interpreted by approved clinicians in the US for patients 18 and over, and it isn't available in New York State. Patients can't buy it directly; ask your clinician. Clinicians can read more about GutID Pro or request a clinician account.
Key differences
- Targeted vs. whole ecosystem. GI-MAP measures a predefined panel. GutID reads every bacterium in the sample to species, with no target list, so it can report organisms no panel was built to find.
- What's covered. GI-MAP's panel spans parasites, fungi, H. pylori and other targets alongside bacteria. GutID's Core and Complete kits read the bacterial community; GutID Pro adds enteric bacteria, enteric viruses, parasites, Candida, H. pylori antigen and stool markers from the same collection.
- What the numbers mean. GI-MAP reports a quantity for each target. GutID reports each species' share of the whole bacterial community, plus diversity and balance across the ecosystem.
- Retesting. A GI-MAP retest shows whether specific targets have changed. A GutID retest shows how the whole bacterial ecosystem has shifted.
Why GutID sees more
A targeted panel answers the questions it was built to ask. qPCR reads a fixed set of chosen targets, so an organism that isn't on the panel isn't detected, and amounts measured one target at a time can't show what share of the community each organism makes up. Titan-1 reads the whole bacterial community instead, which gives a more complete picture of the bacterial ecosystem than a targeted panel can.
- It reads more of each bacterium. Typical short-read 16S tests read a few hundred bases: about 250 for the V4 region, about 460 for V3–V4. Titan-1's read of about 2,500 bases covers 5–10 times more of each bacterium's ribosomal DNA.
- It isn't limited to a reference list. Because the classifier works from the whole long read, novel and uncharacterized bacteria are still separated and counted.
- It's peer-reviewed. More than 30 peer-reviewed publications have used the long-read approach behind Titan-1, in journals including mBio, Microbial Genomics, Scientific Reports, PLOS ONE, Frontiers in Microbiology, ISME Communications, Communications Biology and the International Journal of Molecular Sciences. In a 2022 Microbial Genomics study, Gehrig and colleagues compared sequencing methods on samples from a clinical trial and found that long-read profiling of the 16S-ITS-23S rRNA amplicon provided strain-level community resolution and insight into novel taxa, which short-read 16S profiling did not.
- Pro removes the trade-off. GutID Pro puts the ecosystem and 65 targeted markers in one kit, so clinicians don't have to choose between the whole picture and specific answers.
Read the science behind Titan-1 and the published evidence.
Why the two reports can look different
People who run both tests sometimes see results that seem to disagree. Usually they're measuring different things. A qPCR panel reports how much DNA of each target it found. A sequencing report shows each species as a share of the whole bacterial community. A species can look high as a share of the community and unremarkable as an amount, or the reverse, and an organism that isn't on a qPCR panel can only show up in the sequencing result.
When GI-MAP is the right choice
- A clinician needs quantitative results for named organisms, such as a suspected parasite, H. pylori with its virulence factors, or yeast.
- You want the lab to file the claim with insurance or Medicare, as DSL does for GI-MAP.
- Speed matters: DSL currently quotes 7–10 business days.
Anyone with a suspected acute infection or red-flag symptoms, such as blood in the stool, unexplained weight loss, fever, or severe or persistent diarrhea, should see a clinician for diagnostic testing.
When GutID is the better choice
- You want the whole ecosystem. Diversity, balance and every species present with its relative abundance, rather than results for a list of targets.
- You want what a panel can't name. Titan-1 identifies organisms a fixed panel can't, including novel and uncharacterized bacteria.
- You're tracking change. Retesting shows how the whole community shifts with changes in diet, medication or treatment.
- You want to order it yourself. Core Gut Insights and the Complete Microbiome Assessment need no practitioner's order, ship free both ways and are HSA/FSA eligible in the US. Compare the two kits.
- You're a clinician who wants both. GutID Pro gives you the ecosystem and 65 targeted markers from one collection, in one report.
Frequently asked questions
Is there a GI-MAP alternative?
Yes. To see your gut's bacterial ecosystem as a whole, GutID is an alternative you can order yourself: Titan-1 identifies and measures the bacteria in the sample to species instead of checking a list. Clinicians who also want targeted markers can order GutID Pro, which adds a GI panel, calprotectin, elastase-1, fecal occult blood and H. pylori antigen in the same kit. Other practitioner-ordered stool panels exist too; your clinician can advise which fits.
Is GutID better than GI-MAP?
For seeing the entire bacterial ecosystem, yes. GI-MAP reports the organisms on its panel, while Titan-1 identifies and measures every bacterium in the sample to species, including novel and uncharacterized organisms. It does that from a read 5–10 times longer than a short-read 16S test, with a classifier that isn't tied to a fixed database, and the long-read approach is backed by 30+ peer-reviewed publications. GI-MAP is built for a different job: quantifying specific named organisms. If a clinician wants targeted markers too, GutID Pro adds 65 of them to the Complete Microbiome Assessment.
What does GutID Pro add?
The full Complete Microbiome Assessment, plus 65 markers from a second tube of the same collection: a 30-marker GI panel (enteric bacteria, enteric viruses, parasites and Candida), calprotectin, pancreatic elastase-1, fecal occult blood, H. pylori stool antigen and 31 commensal and dysbiotic bacterial markers. Approved US clinicians order it for patients 18 and over.
Can I get a GI-MAP without a doctor?
DSL says a healthcare practitioner needs to order GI-MAP for you, and it offers to help patients find one. The test can't be ordered in New York State. GutID Core Gut Insights and the Complete Microbiome Assessment can be ordered directly: at time of writing (October 2026), they cost $399 and $599 in the US. For what a GI-MAP costs, see our GI-MAP cost guide.
Does GutID test for parasites?
Core Gut Insights and the Complete Microbiome Assessment read the bacterial community, so they don't test for parasites. GutID Pro, ordered through a clinician, does: its GI panel includes six parasites, along with enteric bacteria, enteric viruses and Candida species.
Sources
- GI-MAP – GI Microbial Assay Plus — Diagnostic Solutions Laboratory (accessed October 30, 2026)
- Finding the right fit: evaluation of short-read and long-read sequencing approaches to maximize the utility of clinical microbiome data (Gehrig et al., 2022) — Microbial Genomics (accessed October 30, 2026)
GutID provides wellness and educational insights and is not a diagnostic test. GI-MAP is a registered trademark of Diagnostic Solutions Laboratory. GutID is not affiliated with Diagnostic Solutions Laboratory.
This article is for education and is not medical advice. GutID provides wellness and educational insights and is not a diagnostic test.

Clinically reviewed by
Head of Clinical Education and Training, GutID
Elena Panzeri is Head of Clinical Education and Training at GutID, where she turns microbiome results into practical guidance for clinicians and the people they treat. She holds an MSc in Nutrition and Genetics from St Mary's University, Twickenham, an MSc in Biology from the University...
More from Elena